Price target
8.670.000.00%
The 3 analysts offering 1 year price forecasts for BCAB have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings to BCAB in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BCAB EPS for the last quarter is −0.22 USD despite the estimation of −0.41 USD. In the next quarter EPS is expected to reach −0.39 USD. Track more of BioAtla, Inc. financials and stay on top of what is up with the company.
In the next quarter BioAtla, Inc. revenue is expected to reach 0.00 USD. Check out BioAtla, Inc. revenue and earnings and make informed decisions.
According to analysts, BCAB price target is 8.67 USD with a max estimate of 13.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch BioAtla, Inc. stock price chart and keep track of the current situation with BCAB news and stock market news.